<DOC>
	<DOCNO>NCT03041740</DOCNO>
	<brief_summary>The primary study objective ass safety feasibility PFOB liquid breathe medium ten day subject severe Bronchopulmonary Dysplasia ( BPD ) .</brief_summary>
	<brief_title>Fluid Filled Lung Oxygenation Assistance Trial</brief_title>
	<detailed_description>The primary study objective ass safety feasibility PFOB liquid breathe medium ten day subject severe BPD evaluate : ( 1 ) sustain oxygen desaturations ( SaO2 ≤ 80 % ) great ten minute without response increase oxygen therapy , ( 2 ) persistent hypotension ( define ≥ 20 % decrease blood pressure ) requiring volume expansion and/or inotropic therapy , ( 3 ) major mucus plug event ( defined event unresolved two bronchoscope ) , ( 4 ) increase mechanical ventilator setting predictive ventilator induce lung injury , ( 5 ) pneumothoraces .</detailed_description>
	<mesh_term>Bronchopulmonary Dysplasia</mesh_term>
	<mesh_term>Perflubron</mesh_term>
	<criteria>Inclusion Criteria 1 . Neonates severe BPD define 36 week post conception age require 30 % O2 great 2 . Infants bear less 32 week post conception age 3 . Subjects may 6 month age 4 . On conventional mechanical ventilation chronic lung disease least two day prior enrollment 5 . On conventional mechanical ventilation time enrollment anticipate continue 14 day 6 . Off systemic steroid 72 hour ( 3 day ) prior T=0 7 . Hemoglobin value ≥8 g/dL : le 8 g/dL , transfusion permit . Clinical blood transfusion administer prior enrollment . 8 . Parental/guardian permission ( informed consent ) Exclusion Criteria 1 . Mechanical ventilation acute disease , infection postoperative complication 2 . Severe Pulmonary Hypertension ( PAH ) ( pulmonary pressure great 2/3 systemic ) define either ECHO , cardiac catheterization CTAngiogram consistent PAH within last 3 week . 3 . Pneumothorax ( active air leak ) require chest tube within 72 hour T=0 4 . Active pulmonary hemorrhage within 72 hour T=0 5 . History Grade III/IV interventricular hemorrhage without resolution stability within 3 week verify eligibility 6 . Severe congenital heart disease compromise pulmonary circulation 7 . Other major congenital malformation ( include limit CDH ) know genetic syndrome discretion investigator 8 . Use investigational drug within 7 day prior confirmation eligibility . 9 . The clinical attending physician believe subject 's and/or parents/guardians best interest participate trial .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>6 Months</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Bronchopulmonary Dysplasia</keyword>
	<keyword>Neonates</keyword>
</DOC>